Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Pharmaceutical Technology
pharmaceutical-technology.com-technology.com

CDC ends universal newborn hepatitis B vaccine recommendations

8+ mon, 1+ week ago   (401+ words) The new guidance marks a major policy shift to the vaccine framework that has been in place since 1991. The US Centers for Disease and Prevention (CDC) no longer recommends that all US newborns receive the hepatitis B vaccine, marking an abrupt…...

Pharmaceutical Technology
pharmaceutical-technology.com-technology.com

FDA actions Tylenol label change after Trump’s autism claim

11+ mon, 3+ day ago   (486+ words) Tylenol’s label change plus the approval of Wellcovorin offer a taste of the Trump administration’s plans to crack down on the US “autism epidemic”. Following US President Donald Trump’s claims that Tylenol (acetaminophen) use in pregnancy can cause autism, the…...

Pharmaceutical Technology
pharmaceutical-technology.com-technology.com

Servier to acquire Fragile X treatment from Kaerus

11+ mon, 2+ week ago   (339+ words) Servier has agreed to acquire Medicxi company Kaerus Bioscience’s potential Fragile X syndrome (FXS) treatment, KER-0193. Servier will pay Kaerus Bioscience upfront, with additional development and commercial earn-out payments that could bring the deal’s total value to $450m. The strategic move…...